DOW JONES28,037.58+76.78 0.27%
S&P 5003,231.74+5.85 0.18%
NASDAQ9,263.04+41.76 0.45%

H.C. Wainwright Downgrades Stealth BioTherapeutics to Neutral

H.C. Wainwright analyst Yi Chen downgrades Stealth BioTherapeutics (NASDAQ:MITO) from Buy to Neutral.

Benzinga · 12/23/2019 12:29

H.C. Wainwright analyst Yi Chen downgrades Stealth BioTherapeutics (NASDAQ:MITO) from Buy to Neutral.